Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
Medical Xpress on MSN8d
Study identifies 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease
Using sequencing techniques, researchers associated 51 mutations in mitochondrial DNA with amyotrophic lateral sclerosis (ALS ...
News Medical on MSN16h
Uncovering the pathway behind ALS neurodegeneration
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for only two to five years after being diagnosed, according to the Centers for ...
Neuroscience News1d
Pathway Identified for Early Intervention in ALS Progression
Researchers have uncovered a mechanism that may trigger ALS’s earliest stages, identifying proteins that mislocalize, causing ...
New research supports brain cell transplantation as a treatment for some neurological disorders
The transplantation of astrocytes — a type of brain cell as common as neurons — may provide hope of treatments or cures of ...
Taiwan News4d
Amyotrophic Lateral Sclerosis (ALS) Market Outlook, Size, Trends, and Growth Opportunities by Type, Treatment, End User, and Region, 2024-2032
Report Ocean, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Amayotrophic Lateral Sclerosis (ALS) Market size by value at USD 902 million in 2023.
University of Denver9d
$2.8M NIH Grant Awarded to DU Professor for Work Toward Dementia Treatment
About 7 million Americans live with chronic neurodegenerative diseases such as Parkinson’s disease, amyotrophic lateral ...
Ancient Viral DNA in the Human Genome Linked to Neurodegenerative Diseases
Scientists have identified a relationship between ancient viral DNA and susceptibility to neurodegenerative diseases like ...
NLS Pharmaceutics and Kadimastem Enter into a Definitive Merger Agreement
ZURICH, SWITZERLAND and NESS ZIONA, ISRAEL / ACCESSWIRE / November 4, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP) ('NLS'), a biopharmaceutical ...
EurekAlert!9d
Identified 51 amyotrophic lateral sclerosis-associated mutations that could help diagnose the disease
The mutations were mapped by a group at the Federal University of São Paulo and collaborators in an analysis of mitochondrial genomes. Thirteen increase the risk of ALS and 38 are protective.